Alternative Splicing of FOXP3 Controls Regulatory T Cell Effector Functions and Is Associated With Human Atherosclerotic Plaque Stability

• Published in: Circulation research Vol. 122; no. 10; pp. 1385 - 1394
• Main Authors: Joly, Anne-Laure, Seitz, Christina, Liu, Sang, Kuznetsov, Nikolai V, Gertow, Karl, Westerberg, Lisa S, Paulsson-Berne, Gabrielle, Hansson, Göran K, Andersson, John
• Format: Journal Article
• Language: English
• Published: United States American Heart Association, Inc 11-05-2018; Lippincott Williams & Wilkins Ovid Technologies
• Subjects: Alternative splicing; Arteriosclerosis; Atherosclerosis; Blindness; Cell activation; Cell lineage; Flow cytometry; Forkhead protein; Foxp3 protein; Immune response; Immunological tolerance; Immunosuppression; Ischemia; Isoforms; Lymphocytes T; Medicin och hälsovetenskap; Phenotypes; Plaques; Polymerase chain reaction; Transcription; Transforming growth factor; Transforming growth factor-b; Transient ischemic attack; atherosclerosis; T-lymphocytes; alternative splicing; cell lineage; inflammation; transcription factors
• ISSN: 0009-7330; 1524-4571; 1524-4571
• DOI: 10.1161/CIRCRESAHA.117.312340

RATIONALE:Regulatory T (Treg) cells suppress immune responses and have been shown to attenuate atherosclerosis. The Treg cell lineage-specification factor FOXP3 (forkhead box P3) is essential for Treg cells’ ability to uphold immunologic tolerance. In humans, FOXP3 exists in several different isoforms, however, their specific role is poorly understood.
OBJECTIVE:To define the regulation and functions of the 2 major FOXP3 isoforms, FOXP3fl and FOXP3Δ2, as well as to establish whether their expression is associated with the ischemic atherosclerotic disease.
METHODS AND RESULTS:Human primary T cells were transduced with lentiviruses encoding distinct FOXP3 isoforms. The phenotype and function of these cells were analyzed by flow cytometry, in vitro suppression assays and RNA-sequencing. We also assessed the effect of activation on Treg cells isolated from healthy volunteers. Treg cell activation resulted in increased FOXP3 expression that predominantly was made up of FOXP3Δ2. FOXP3Δ2 induced specific transcription of GARP (glycoprotein A repetitions predominant), which functions by tethering the immunosuppressive cytokine TGF (transforming growth factor)-β to the cell membrane of activated Treg cells. Real-time polymerase chain reaction was used to determine the impact of alternative splicing of FOXP3 in relation with atherosclerotic plaque stability in a cohort of >150 patients that underwent carotid endarterectomy. Plaque instability was associated with a lower FOXP3Δ2 transcript usage, when comparing plaques from patients without symptoms and patients with the occurrence of recent (<1 month) vascular symptoms including minor stroke, transient ischemic attack, or amaurosis fugax. No difference was detected in total levels of FOXP3 mRNA between these 2 groups.
CONCLUSIONS:These results suggest that activated Treg cells suppress the atherosclerotic disease process and that FOXP3Δ2 controls a transcriptional program that acts protectively in human atherosclerotic plaques.